Latest Breaking News On - Anne hennecke julia bittner - Page 1 : comparemela.com

EQS-News: Imcyse joins CLAIMS, a European Health Initiative Project to Make Data-Driven Precision Medicine a Reality for Patients with Multiple Sclerosis

EQS-News: Imcyse SA / Key word(s): Miscellaneous Imcyse joins CLAIMS, a European Health Initiative Project to Make Data-Driven Precision Medicine a Reality for Patients with Multiple Sclerosis 22.06.2023 / 10:30 CET/CEST The issuer is solely responsible for the content of this announcement. Imcy.

Region flamandeAnne hennecke julia bittnerRuhr universitaet bochumMedtech europeChuck padalaBristol myers squibbCura igeaJean van rampelberghDenis bedoretEuropean union horizon europeEuropean health initiative project to make dataMc servicesEuropean innovative health initiativeDistribution servicesInnovative health initiative joint undertakingEuropean charcot foundation

EQS-News: Imcyse SA: Imcyse joins CLAIMS, a European Health Initiative Project to Make Data-Driven Precision Medicine a Reality for Patients with Multiple Sclerosis

EQS-News: Imcyse SA: Imcyse joins CLAIMS, a European Health Initiative Project to Make Data-Driven Precision Medicine a Reality for Patients with Multiple Sclerosis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Region flamandeJean van rampelberghChuck padalaCura igeaDenis bedoretAnne hennecke julia bittnerRuhr universitaet bochumBristol myers squibbMedtech europeCatholic university of leuvenEuropean charcot foundationInnovative health initiative joint undertakingEuropean innovative health initiativeEuropean health initiative project to make dataCentre hospitalier universitaire de lilleMc services

Imcyse Announces Completion of Enrollment in Phase 2 IMPACT Trial of IMCY-0098 for Type 1 Diabetes

Exceeded target enrollment with 110 patients randomized across 28 clinical sites in Europe, the United States and AustraliaEfficacy proof-of-concept data from IMPACT is expected in Q1 2024. Following

Walloon regionWaals gewestRegion flamandeUnited statesDennis riedlDenis bedoretAnne hennecke julia bittnerJean van rampelberghChuck padalaMc servicesEuropean commissionInnovative medicines initiativeClinical developmentCatholic university of leuvenVan rampelberghUnited kingdom

EQS-News: Imcyse Announces Completion of Enrollment in Phase 2 IMPACT Trial of IMCY-0098 for Type 1 Diabetes

EQS-News: Imcyse SA / Key word(s): Study Imcyse Announces Completion of Enrollment in Phase 2 IMPACT Trial of IMCY-0098 for Type 1 Diabetes 01.03.2023 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. Imcyse Announces Completion of Enrollment in Phase 2 IMPA.

Walloon regionWaals gewestRegion flamandeUnited statesDenis bedoretAnne hennecke julia bittnerJean van rampelberghChuck padalaMc servicesEuropean commissionInnovative medicines initiativeClinical developmentCatholic university of leuvenDistribution servicesAnnounces completionVan rampelbergh

DGAP-News: Imcyse Announces First Patient Dosed in Adaptive Phase 1/2 Clinical Trial of ImotopeTM IMCY-0141 for Multiple Sclerosis

DGAP-News: Imcyse SA / Key word(s): Study 13.04.2022 / 13:00 The issuer is solely responsible for the content of this announcement. Imcyse Announces First Patient Dosed in Adaptive Phase 1/2 Clinical Trial of ImotopeTM IMCY-0141 for Multiple Sclerosis IMCY-MS-001 study aims to determine safe.

Walloon regionWaals gewestRegion flamandeDenis bedoretAnne hennecke julia bittnerPatrick vermerschJonathan nugentAndrew mackieMc servicesUniversity of lilleCatholic university of leuvenDistribution servicesAnnounces first patient dosedMyelin oligodendrocyte glycoproteinCatholic universityMedia inquiries